These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7814188)

  • 61. [Chronic exposure to solvents and liver enzymes. An occupational medicine field study].
    Triebig G; Weltle D; Schaller KH; Valentin H
    Fortschr Med; 1985 Mar; 103(10):271-4. PubMed ID: 2858436
    [No Abstract]   [Full Text] [Related]  

  • 62. Initial experience with hirudin and streptokinase in acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 6 trial.
    Lee LV
    Am J Cardiol; 1995 Jan; 75(1):7-13. PubMed ID: 7801868
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Life-threatening, localized angio-oedema associated with streptokinase.
    Cooper JP; Quarry DP; Beale DJ; Chappell AG
    Postgrad Med J; 1994 Aug; 70(826):592-3. PubMed ID: 7937456
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Heparin and infarct coronary artery patency after streptokinase in acute myocardial infarction.
    Mahan EF; Chandler JW; Rogers WJ; Nath HR; Smith LR; Whitlow PL; Hood WP; Reeves RC; Baxley WA
    Am J Cardiol; 1990 Apr; 65(15):967-72. PubMed ID: 2327357
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Delayed rupture of the spleen and streptokinase therapy.
    Nam R; Carr MM; Jamieson CG
    Can J Surg; 1996 Apr; 39(2):151-4. PubMed ID: 8769927
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Acute iritis and transient renal impairment following thrombolytic therapy for acute myocardial infarction.
    Birnbaum Y; Barash D; Rechavia E; Regev A; Stahl B; Mager A
    Ann Pharmacother; 1993 Dec; 27(12):1539-40. PubMed ID: 8305792
    [No Abstract]   [Full Text] [Related]  

  • 67. Thrombolytic failure with streptokinase in acute myocardial infarction using electrocardiogram criteria.
    Lee YY; Tee MH; Zurkurnai Y; Than W; Sapawi M; Suhairi I
    Singapore Med J; 2008 Apr; 49(4):304-10. PubMed ID: 18418522
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Letter: Gamma-glutamyl transferase and transaminases].
    Schmidt E
    Dtsch Med Wochenschr; 1975 Mar; 100(13):713. PubMed ID: 235414
    [No Abstract]   [Full Text] [Related]  

  • 69. [Sudden rise in liver transaminase activities].
    Holstege A
    MMW Fortschr Med; 2014 Feb; 156(3):62-3. PubMed ID: 24938069
    [No Abstract]   [Full Text] [Related]  

  • 70. [Thrombolytic therapy in acute myocardial infarction hospitalized in a general internal medicine ward].
    Błasiak M; Zawadowicz B; Pacyk G
    Pol Tyg Lek; 1993 Apr 5-12; 48(14-15):316-7. PubMed ID: 8415244
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Diffuse pulmonary hemorrhage after fibrinolytic therapy for acute myocardial infarction.
    Masip J; Vecilla F; Páez J
    Int J Cardiol; 1998 Jan; 63(1):95-7. PubMed ID: 9482153
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Is thrombolytic therapy in acute inferior myocardial infarction really better than conventional treatment?
    Tobé TJ
    Br Heart J; 1995 Feb; 73(2):108-9. PubMed ID: 7696015
    [No Abstract]   [Full Text] [Related]  

  • 73. Variations in patient management and outcomes for acute myocardial infarction in the United States and other countries. Results from the GUSTO trial. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
    Van de Werf F; Topol EJ; Lee KL; Woodlief LH; Granger CB; Armstrong PW; Barbash GI; Hampton JR; Guerci A; Simes RJ
    JAMA; 1995 May 24-31; 273(20):1586-91. PubMed ID: 7745771
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Stroke after thrombolysis. Mortality and functional outcomes in the GUSTO-I trial. Global Use of Strategies to Open Occluded Coronary Arteries.
    Gore JM; Granger CB; Simoons ML; Sloan MA; Weaver WD; White HD; Barbash GI; Van de Werf F; Aylward PE; Topol EJ
    Circulation; 1995 Nov; 92(10):2811-8. PubMed ID: 7586246
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Evaluation and comparison of the adverse effects of streptokinase and alteplase.
    Tisdale JE; Colucci RD; Ujhelyi MR; Kluger J; Fieldman A; Chow MS
    Pharmacotherapy; 1992; 12(6):440-4. PubMed ID: 1492007
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Coronary thrombolysis: hemorrhagic complications.
    Hirsh J
    Can J Cardiol; 1993; 9(6):505-11. PubMed ID: 8221344
    [No Abstract]   [Full Text] [Related]  

  • 77. Early angiography cannot predict postthrombolytic coronary reocclusion: observations from the GUSTO angiographic study. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries.
    Reiner JS; Lundergan CF; van den Brand M; Boland J; Thompson MA; Machecourt J; Py A; Pilcher GS; Fink CA; Burton JR
    J Am Coll Cardiol; 1994 Nov; 24(6):1439-44. PubMed ID: 7930273
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Atheromatous material mobilization syndrome after thrombolytic therapy with streptokinase in acute myocardial infarct].
    Arpesani A; Beretta L; Giorgetti PL; Varesi C; Matturri L
    Minerva Cardioangiol; 1991 Jun; 39(6):251-4. PubMed ID: 1961445
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Preliminary safety and tolerance data obtained in the comparative study of anisoylated plasminogen streptokinase activator complex versus heparin.
    Croydon EA
    Drugs; 1987; 33 Suppl 3():293-6. PubMed ID: 3315611
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Serum D-glutamyl transferase following myocardial infarction.
    Connell MD
    J Clin Pathol; 1973 Sep; 26(9):684-6. PubMed ID: 4148076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.